top of page

Press Releases

Preclinical Studies: ANN-102 for Sarcopenia

Anodyne Nanotech Drives Major Advancement in the Treatment of Sarcopenia with Novel Muscle-Preserving Therapy

HeroPatch_ANN102_Businesswire

JUNE 9 2025

JPM 2025

Meet Anodyne at JPM Healthcare Week 2025

Anodyne_JPM2025.png

JANUARY 12 2025

Preclinical Studies: Once-weekly GLP1 patch

Anodyne Nanotech Achieves Breakthrough in Transdermal Delivery of GLP-1 Drugs

pressrelease_businesswire_GLP1.png

DECEMBER 19 2024

Business Wire

Successful GLP-1 Data

Anodyne Presents Successful Preclinical Data of a Once-Weekly GLP-1RA Patch at PODD 2024 in Boston, MA

PODD_Anodyne.png

OCTOBER 25 2024

Board of Directors

Anodyne Nanotech, Inc. Appoints Jeff Mihm to its Board of Directors.

Pressrelease_businesswire_BOD.png

FEBRUARY 6 2023

Business Wire

bottom of page